INTRODUCTION
Alzheimer's disease (AD) is a progressive and fatal neurodegenerative disorder manifested by cognitive and memory deterioration, progressive impairment of activities of daily living, and a variety of neuropsychiatric symptoms and behavioral disturbances. For 70 years after Alois Alzheimer (1864-1915) described a disorder of tangle-and-plaque dementia in 1907, Alzheimer's disease was a condition of relatively young. Definitions of AD have changed over the past 30 years and under the revised view AD has truly become an age-related disease and has been recognised as a major public health problem.
The pathomechanism of AD has been researched intensively. The novel drugs can slow down the progression of the disorder in the early phase. Histopathological confirmation of AD in vivo is extremly rare, so the diagnosis is probable AD. There is an increasing need for the biological markers, which would detect the fundamental neuropathology of AD.
The characteristic histopathological changes (plaques and neurofibrillary tangles) occur long before the clinical symptoms in AD. The plaques and neurofibrillary tangles were rarely detected in normal ageing, but frequently appear in mild cognitive impairment, which suggests MCI is a transitional state between normal ageing and AD.
Mild Cognitive Impairment (MCI)
MCI can present with a variety of symptoms and when memory loss is the predominant symptom, it is termed "amnestic MCI" (aMCI). Patients with MCI have a memory impairment that is out of proportion to that expected for their age, yet they do not meet commonly accepted criteria for dementia (or AD), and longitudinal outcome results indicate that they are likely to progress to AD at an accelerated rate (10% to 15% per year).
Heterogeneity of MCI means that individuals who clinically present mild cognitive symptoms may not all share the same ultimate fate. Some develop AD later, while others may progress to another type of dementia, and still some will never progress to any significant extent.
Memory impairment is usually the initial manifestation of dementia in AD, which can be characterised as MCI. On the other hand, in some cases a small vascular damage may occur in the brain, causing mild cognitive impairment, before VD develops. However, cerebral atrophy or lacunar infarcts do not necessarily go parallel with dementia.
MCI and cerebrovascular disease
Cerebrovascular disease is a common symptom of the ageing process, and several studies suggest that cerebrovascular risk factors are strongly associated with prevalent dementia, including AD. Individuals identified as having MCI showed significantly increased frequencies of vascular risk factors and evidence of vascular brain injury.
Dementia and depression
In the early phase of AD, depression can mask the cognitive impairment ("pseudodepression"), and late life depression often goes with cognitive impairment ("pseudodementia"). Demented patient can be depressed or comorbid depression may occur beside dementia. All of these make the differential diagnosis difficult.
Neuropsychological symptoms in dementia and depression
In AD neurofibrillary tangles and amyloid plaques were found in mediotemporal lobe, especially in the entorhinal cortex. There is an early cingular atrophy with damage of connection between associate neocortex and mediotemporal lobe, resulting in short term memory loss. The next damage occurs in the associate neocortex, leading to agnosia, aphasia and apraxia. Motor and sensory functions are saved for a long time during the disorder.
Executive functions are a complex mental process based on working memory, resulting the information turnover and problem solving, and are disturbed in AD.
Previous studies of cognitive impairment in unipolar depression have demonstrated impairments in psychomotor speed, memory, sustained attention and executive functions, including working memory and complex problem solving, but findings across studies have been somewhat inconsistent. Patients with remitted depression were impaired on tasks of rapid visual information processing, psychomotor performance, and spatial working memory.
After correction for residual depressive symptoms, deficit in sustained attention remained significant suggesting it is a good vulnerability marker for major depressive disorder.
Electrophysiological methods in dementia
In the conventional EEG frontal slow waves are present in AD, but in the early phase no characteristic features were found. The late component of the auditory event-related cortical potential (AEP), P300 reflects cognitive processing, such as stimulus registration, attention, stimulus evaluation, and memory. P300 latency is thought to indicate the speed of information processing, delayed latency relates to slowed cognitive function in normal elderly, as well as 
MATERIALS AND METHODS
The patients were selected from the in-and outpatient units of the Department of Psychiatry, Medical and Health Science Center, University of Debrecen. Patients were diagnosed according to the ICD-10 and DSM-IV diagnostic criteria system, NINCDS-ADRDA and NINDS-AIREN criteria. Dementia caused by other possible diseases was excluded. All participants had laboratory tests: serum ion, enzyme levels, thyroid-, liver-, and kidney function, lipid levels, urine examination, blood count, erythrocyte sedimentation rate, vitamin B12 level, folic acid level, hemostasis, VDRL, apoE genotype, chest X-ray, EEG, CT/MRI examination. Cerebral SPECT and carotid Doppler examination were also performed when it was clinically indicated. The differencial diagnosis between AD and VD was based on the Hachinski Ischemic Scale, laboratory tests, anamnestic data, imaging investigations and attending illnesses. MD patients were assessed by Hamilton Depression Scale. Healthy control subjects were included in the study after general physical examination, and routine laboratory tests, in case of negative neurological and psychiatric anamnesis, and MMSE score between 27 and 30 points. All subjects were informed about the study and gave their written consent to participation. The study was conducted according to the principles of the Helsinki Declaration. Results were compared to the internal normative database of CANTAB, involving 3,000
CANTAB
healthy volunteers, and were matched for age groups and gender. CANTAB tests were previously validated among Hungarian healthy volunteers showing no statistically significant differences in the cognitive performance compared to the internal normative database. P300 latency was determined at the centroparietal peak amplitude (Cz) and amplitudes were measured. The mean values of P300 latency and amplitude were calculated based on a peakto-peak method. The time window was 256-500 ms. The internal artefact-rejector of the apparatus was used during recording to include only artifact-free targets in the calculation of the ERP waveforms. For group comparison analysis, a one-way non-parametric ANOVA was used. The correlation of different variables was analysed by the Spearman non-parametric method. P values less than 0.05 were considered as significant. Statistical calculations were carried out using the GraphPad Prism 4.00 for Windows software (GraphPad Software, San Diego, CA, USA, http://www.graphpad.com).
Lipid parameters and paraoxonase (PON) activity in the sera
30 (N/F: 20/10) AD, 40 (N/F: 27/13) VD patients and 40 (N/F: 26/14) non-demented consenting healthy control subjects were included (Table 7) . Lipid parameters were determined by an autoanalyser. PON activity was measured spectrophotometrically using paraoxon as the substrate. (N/F: 6/9) non-demented consenting patients' CSF IDP level (Table 8) . Controls were undergoing spinal anesthesia for inguinal hernia operation or varix removal from the lower extremities respectively. Free IDP concentration of CSF was determined from protein-free ultrafiltrate of lumbar CSF using internal 3 H-N ε (γ-glutamyl)lysine internal standard tracer and precolumn phenylisothiocyanate derivatization followed by C18 HPLC separation as described. n.s.= not significant n.s.= not significant P300 Table 5 . Mean P300 latency and amplitude for the AD and VD patients, and control group A.
RESULTS
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Subject groups Mean age ± ± ± ± SD (years)
MMSE score (mean ± ± ± ± SD) P300 latency (msec) (mean ± ± ± ± SD) Table 6 . Mean P300 latency and amplitude in the two groups of subjects with MCI and control group B.
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DISCUSSION
CANTAB
The present results show that several cognitive domains are already impaired in patients with MCI, and in AD patients several other cognitive domains show impairment and the severity of the cognitive dysfunctions is more pronounced.
Visual Paired Associate Learning (PAL test) was significantly (p<0.05) impaired among subjects with AD and MCI. A successful performance in the PAL test requires both the elaboration of "frontal strategies" and the "mnemonic processes" of the medial temporal lobe.
MCI patients performed poorly on this test, as did AD patients, which suggests that they may already be in the early stage of the disease. Several studies, including functional brain imaging experiments, have shown a dysfunction of the medial temporal lobe in the early phase of dementias and schizophrenia. Furthermore, elderly subjects with major depression also perform poorly on tests of memory, as do AD subjects; thus, the specificity of such tests is particularly crucial for being able to differentiate the AD individuals. Refinement of the sensitivity of neuropsychological tests would allow possible disease-modifying treatments to be employed at the earliest stages of neuronal loss.
P300
In line with the literature the obtained results confirm previously reported findings that P300 latencies are significantly prolonged among patients with both vascular and Alzheimer's dementia, and amplitudo was decreased. Also, no significant differences of mean P300 latencies between the AD and the VD patients were found. Prolonged P300 latency in both types of dementia is associated with the dysfunctions of the neuropsychological processes involved in P300 generation. The present results confirm previous results that the severity of dementia and the prolongation of P300 latency are correlated; therefore, the prolongation of P300 latency reflects the severity of dementia, but not the type of dementia. MCI subjects with mild cerebral atrophy had a prolongation of P300 latency similar to that observed in demented patients, while in MCI patients with normal brain structure, the P300 latency was not altered. This may suggest that P300 latency prolongation can be connected with the structural brain damage detectable in MCI patients and that the complex cognitive disturbances are already present in this group of MCI patients.
Paraoxonase (PON)
Most of the patients with AD had the apoE4 isoform, consistently with other studies. We found significantly higher total-cholesterol and LDL-cholesterol levels in AD and VD patients compared to the control group. The HDL-associated paraoxonase activity was significantly lower in both patient groups, but did not differ in AD from VD. The results suggest that the defect in PON antioxidant capacity plays a role in the pathogenesis both of AD and VD. higher age is associated with higher IDP level, which reflects an increasing intensity of apoptotic cell turnover with age. There is not enough evidence to recommend one specific technique for the prediction and early detection of AD. A combined use of cognitive tests, ApoE genotype, functional and structural neuroimaging techniques, the serum and cerebrospinal fluid measurements is probably the best option.
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